You are here

Translational research platforms integrating clinical and omics data: a review of publicly available solutions.

Submitted by karopka on Mon, 2015/10/26 - 10:34
TitleTranslational research platforms integrating clinical and omics data: a review of publicly available solutions.
Publication TypeJournal Article
Year of Publication2015
AuthorsCanuel, V, Rance, B, Avillach, P, Degoulet, P, Burgun, A
JournalBrief Bioinform
Date Published2015 Mar

The rise of personalized medicine and the availability of high-throughput molecular analyses in the context of clinical care have increased the need for adequate tools for translational researchers to manage and explore these data. We reviewed the biomedical literature for translational platforms allowing the management and exploration of clinical and omics data, and identified seven platforms: BRISK, caTRIP, cBio Cancer Portal, G-DOC, iCOD, iDASH and tranSMART. We analyzed these platforms along seven major axes. (1) The community axis regrouped information regarding initiators and funders of the project, as well as availability status and references. (2) We regrouped under the information content axis the nature of the clinical and omics data handled by each system. (3) The privacy management environment axis encompassed functionalities allowing control over data privacy. (4) In the analysis support axis, we detailed the analytical and statistical tools provided by the platforms. We also explored (5) interoperability support and (6) system requirements. The final axis (7) platform support listed the availability of documentation and installation procedures. A large heterogeneity was observed in regard to the capability to manage phenotype information in addition to omics data, their security and interoperability features. The analytical and visualization features strongly depend on the considered platform. Similarly, the availability of the systems is variable. This review aims at providing the reader with the background to choose the platform best suited to their needs. To conclude, we discuss the desiderata for optimal translational research platforms, in terms of privacy, interoperability and technical features.

Alternate JournalBrief. Bioinformatics
PubMed ID24608524
PubMed Central IDPMC4364065
No votes yet
Related project(s):